L. Chan

Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II

W. Heneine, R. Khabbaz, G. Reyes, 1993, Journal of clinical microbiology.

Serologic confirmation of simian T-lymphotropic virus type I infection by using immunoassays developed for human T-lymphotropic virus antibody detection

G. Reyes, J. Lipka, M. Lairmore, 1992, Journal of clinical microbiology.

Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations.

G. Reyes, B. Hjelle, J. Lipka, 1992, The Journal of infectious diseases.

Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes.

W. Blattner, G. Shaw, G. Reyes, 1992, The Journal of infectious diseases.

A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation

S. Wechsler, L. BenMohamed, Xianzhi Jiang, 2015, Journal of NeuroVirology.

Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.

J. Coligan, R. Khabbaz, G. Reyes, 1993, Clinical immunology and immunopathology.

Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins

R. Lal, W. Switzer, S. Foung, 1995, Journal of clinical microbiology.

Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.

W. Blattner, J. Sninsky, G. Shaw, 1991, The Journal of infectious diseases.